BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 27, 2009
View Archived Issues
Odanacatib progressively increases bone mineral density in postmenopausal women over 2 years
Read More
Quetiapine improves PTSD measures in randomized study
Read More
Novel oxazolidinone shows preclinical antibacterial activity and clinical safety in healthy subjects
Read More
Sanofi-aventis presents novel histamine H3 receptor modulators for sleep disorders
Read More
Allergan claims prostanoid EP2 receptor agonists for the treatment of glaucoma
Read More
Genzyme reviews developments of first quarter
Read More
Glomerular filtration rate improved with pirfenidone in diabetic nephropathy patients
Read More
Denosumab: Snapshots of recent clinical and preclinical studies
Read More
Merck KGaA prepares and tests novel 11beta-HSD1 inhibitors
Read More
Abbott presents 5-HT6 receptor ligands for the treatment of cognitive dysfunctions
Read More
Bristol-Myers Squibb discloses androgen receptor antagonists for the treatment of cancer
Read More
Acure initiates phase I clinical trial of novel compound for RA and pain relief
Read More
COMP issues positive opinion for orphan drug designation for Camurus' CAM-2029
Read More
CTx progresses preclinical cancer drug against FAK enzyme into lead optimization phase
Read More
Amgen exercises option to licence Cytokinetics' cardiac contractility program
Read More
Novel dual muscarinic antagonist and beta2-adrenoceptor agonist developed for bronchodilator therapy
Read More
Dr. Reddy's receives approval for INDs and reorganizes drug discovery operations
Read More
Muscarinic receptor antagonist TD-4208 shows preclinical potential for the treatment of COPD
Read More
Novel histamine H3 receptor inverse agonist developed by Roche for the treatment of obesity
Read More
FDA accepts Allos' pralatrexate NDA for filing and grants priority review
Read More
Long-term fermagate treatment holds down phosphate levels in hemodialysis patients
Read More
FDA approves Adcirca tablets for pulmonary arterial hypertension
Read More
FDA notifies Hemispherx of possible delay in FDA action on Ampligen
Read More
Health Canada approves GSK's Tykerb in combination with Xeloda for breast cancer
Read More
Bristol-Myers Squibb submits CTA in Sweden to initiate phase I studies on drug for CNS diseases
Read More
European Commission grants marketing authorization to HRA Pharma's ellaOne
Read More